XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Cancer

Cancer Channel
subscribe to Cancer newsletter

Latest Research : Cancer

   DISCUSS   |   EMAIL   |   PRINT
African-American women with uterine cancer have worse survival rates
Sep 25, 2006 - 6:43:00 PM, Reviewed by: Dr. Rashmi Yadav

"While the causes of this survival difference remain to be elucidated, socioeconomic, biologic and cultural etiologies may be involved."

 
African-American women with uterine cancer have worse survival rates than Caucasian women who received similar treatment even though they had similar prognostic factors, according to a new review of four clinical trials. Published in the November 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the review found significant racial disparities in survival and clinical presentation of advanced/recurrent endometrial cancer. African-Americans presented with worse disease, but even after controlling for clinical features and treatment, African-Americans survived significantly fewer months than Caucasians, suggesting that other factors, such as socioeconomic, biologic, and cultural issues may have a strong influence on this disease outcome.

Ethnic and racial differences are observed in many cancers, such as breast and colon cancers. Population-based studies have also demonstrated clear racial disparities in the presentation, course and outcome of endometrial cancer. These studies clearly show that African-Americans present with more advanced disease and have lower survival rates than other racial groups. Analysis suggests that the cause is multifactorial and may be related to inequality of access to healthcare, cultural variations in response to disease, and differences in disease stage at presentation. Etiology, however, is difficult to discern due to methodological shortcomings in many studies, such as too few patients.

To further characterize the cause of outcome differences between African-Americans and Caucasians, G. Larry Maxwell, M.D. of the Department of Obstetrics and Gynecology at the Walter Reed Army Medical Center in Washington, DC and investigators analyzed demographic and clinical data from 1,151 patients who were enrolled in any of four randomized, control treatment trials with stage III, IV or recurrent endometrial cancer.

The authors identified racial disparities in outcome, even after controlling for presentation and treatment. African-Americans were at 26 percent greater risk of death from uterine cancer than Caucasians, even if they had similar diseases and treatments. "When response to treatment was analyzed, Blacks appeared to have lower tumor response to each of the chemotherapy regimens employed in the trials," the authors observe.

Analyzed by time, Africans-Americans survived a median 10.6 months compared to 12.2 months among Caucasians. At presentation, African-Americans were more likely than Caucasians to present with more serious disease, including papillary serous histology, stage IV disease, and higher tumor grade.

"While the causes of this survival difference remain to be elucidated, socioeconomic, biologic and cultural etiologies may be involved," conclude the authors.
 

- The study is published in the November 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
 

http://www.interscience.wiley.com/

 
Subscribe to Cancer Newsletter
E-mail Address:

 

Article: "Racial Disparity in Survival among Patients with Advanced/Recurrent Endometrial Adenocarcinoma: A Gynecologic Oncology Group Study," G. Larry Maxwell, Chunqiao Tian, John Risinger, Carol L. Brown, G. Scott Rose, J. Tate Thigpen, Gini F. Fleming, Holly H. Gallion, Wendy R. Brewster, CANCER; Published Online: September 25, 2006 (DOI: 10.1002/cncr.22232); Print Issue Date: November 1, 2006.

Related Cancer News

Gene Expression Profiling Not Quite Perfected in Predicting Lung Cancer Prognosis
Breast cancer chemotherapy may deterioration in cognitive function
I-ELCAP study: Lung cancer can be detected early with annual low-dose CT screening
Genomic signatures to guide the use of chemotherapeutics
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Listening to the sound of skin cancer
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
CDK2/FOXO1 as drug target to Prevent Tumors
Key to lung cancer chemotherapy resistance revealed


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us